Platform Releases

3 min

New feature: Introducing AI Summaries for Canopy

Synthesize multiple expert insights into comprehensive summary reports in seconds.

Expert Insights

5 min

Modernizing Due Diligence for Private Equity - Key Insights

Highlights from our recent webinar on Modernizing Due Diligence Processes for Private Equity with Colin McIntyre and Johnathan Tran.

Platform Releases

4 min

Arbolus Product Update - July 2023

A quick roundup of the latest Arbolus features, updates and UI improvements designed to enhance your Arbolus platform experience.

Webinars

5 min

Generative AI Unpacked - Your Questions Answered

Audience questions from our recent webinar answered by our experts through ArbolusCanopy. During our recent webinar "Generative AI Unpacked: Navigating the Hype for Businesses and Investors" we...

Webinars

8 min

Generative AI Unpacked - Key insights from the webinar

Check out some key insights from our recent webinar on generative AI for Businesses and Investors

Arbolus Journey

3 min

Arbolus: Changing the Expert Network Industry with Generative AI and ArbolusCanopy

Our innovative platform, ArbolusCanopy, is changing the way our investment and consulting clients gather information.

Platform Releases

3 min

Arbolus Product Update - March 2023

The latest Arbolus features, updates and UI improvements designed to enhance your Arbolus platform experience.

Case study

1 min

How ArbolusCanopy fast-tracked market research for a growing HealthTech

Check out how ArbolusCanopy allowed the client to confidently validate their product positioning, without spending hours on interviews.

Expert Insights

5 min

The Impact of AI and Blockchain Technology on Clinical Trials

We asked a curated panel of top experts on ArbolusChannels how AI and blockchain technologies will impact the industry.

Arbolus Journey

1 min

Arbolus ranked in the top 25 in the FT 1000 Fastest Growing European Companies report 2023

With revenue growth of over 4000%, Arbolus confidently secured 23rd place on the ranking, in the report by Statista and Financial Times.

Expert Insights

5 min

Key Insights from the webinar "3 Major Disruptions to Clinical Trials"

Key ideas and insights on major disruptions to Clinical trials discussed during our recent webinar with Chris Baker and Jon Shephard.

Case study

1 min

Attributable results from niche populations with Arbolus Surveys

Find out how Arbolus ensured the success of the client survey in EdTech space.

Case study

1 min

How ArbolusCanopy accelerated decision-making for a leading VC

Check out how ArbolusCanopy helped a renowned VC firm to quickly test their hypothesis early in their due diligence process.

Case study

1 min

70% faster research process with ArbolusCanopy

How Canopy helped a leading private equity firm to gather critical insights faster.

Webinars

1 min

On-demand Webinar: 3 Major Disruptions to Clinical Trials in 2023

Watch our on-demand webinar with Chris Baker, President at ICON, Symphony Health and Jon Shephard, a Partner at PwC.

Success Stories

1 min

How ArbolusCanopy reduced project turnaround by 80%

ArbolusCanopy enabled a Big 4 Consulting client to gather all required insights without conducting any calls.

Growth Matters

5 min

The North Star Metric: A Product Tale

The importance and the challenges for companies to define a path towards product-led sustainable business results and customer value.

Success Stories

4 min

Ditching paper in healthcare: intelligent operations

As we transition to a paperless future, we look at how the adoption of digital processes is transforming healthcare operations.

Expert Insights

3 min

The Turning Point: E-commerce & Covid

How has the pandemic affected retail and how to thrive in an online marketplace: Head of E-commerce at Amazon.

Expert Insights

3 min

CannaTech: how are data & technology changing the legal cannabis industry?

How can data and technology play a role in establishing the safety, efficiency and legitimacy of the legal cannabis industry?

Expert Insights

3 min

Is private equity changing the face of sport?

In light of recent events and growing investment activity, we look at why sports assets represent a challenge for investors